Profil

MENTEN Catherine

Unilab > Laboratoire Cytogénétique

See author's contact details
Main Referenced Co-authors
Baron, Frédéric  (14)
Beguin, Yves  (13)
Hannon, Muriel  (12)
Belle, Ludovic  (10)
Briquet, Alexandra  (10)
Main Referenced Keywords
Animals (2); Female (2); GvHD (2); Rapamycin (2); SV2A (2);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (2)
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège (1)
Laboratory of Human Histology - Centre de recherche sur les protéines Prion (CRPP), University of Liege, Avenue de l'Hopital, 1, B-4000 Liege, Belgium. (1)
Main Referenced Disciplines
Hematology (11)
Immunology & infectious disease (3)
Genetics & genetic processes (3)
Laboratory medicine & medical technology (2)
Radiology, nuclear medicine & imaging (2)

Publications (total 26)

The most downloaded
356 downloads
Belle, L., Binsfeld, M., Dubois, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & BARON, F. (2013). Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin [Poster presentation]. BMT Tandem Meetings (ASBMT), Salt Lake City, United States. https://hdl.handle.net/2268/143760

The most cited

66 citations (Scopus®)

Beaufays, J., Adam, B., Menten, C., Fievez, L., Grosjean, A., Decrem, Y., Prevot, P.-P., Santini, S., Brasseur, R., Brossard, M., Vanhaeverbeek, M., Bureau, F., Heinen, E., Lins, L., Vanhamme, L., & Godfroid, E. (2008). Ir-LBP, an ixodes ricinus tick salivary LTB4-binding lipocalin, interferes with host neutrophil function. PLoS ONE, 3 (12), 3987. doi:10.1371/journal.pone.0003987 https://hdl.handle.net/2268/63280

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

LETE, C., Ameye, G., BECKERS, P., Michaux, L., BOURS, V., JAMAR, M., De Bie, J., Dewaele, B., & MENTEN, C. (July 2021). CASE REPORT: the use of optical genome mapping (Bionano) to understand a complex mechanism of a KMT2A rearrangement in an AML case [Poster presentation]. 13th European Cytogenomics Conference.

JAMAR, M., HARVENGT, J., D'OTREPPE DE BOUVETTE, S., Florkin, B., & MENTEN, C. (September 2018). Diagnostic moléculaire par CGH-array + SNP d'un cas d'Anémie de Fanconi [Poster presentation]. XXIVe Colloque Association des Cytogénéticiens de Langue Française (ACLF), Saint-Malo, France.

JAMAR, M., MENTEN, C., GRISART, B., & GATOT, J.-S. (September 2018). Trisomie 9 détectée en DPNI : à propos de deux cas de mosaïcisme [Poster presentation]. XXIVe Colloque Association des Cytogénéticiens de Langue Française (ACLF), Saint-Malo, France.

Bartholomé, O., Van Den Ackerveken, P., Wislet, S., Leprince, P., Rogister, B., MENTEN, C. (Other coll.), Serrano Navacerrada, M. E. (Other coll.), Neirincks, V. (Other coll.), Becker, G. (Other coll.), & Plainevaux, A. (Other coll.). (October 2016). Study of the SV2A protein role in Epilepsy [Poster presentation]. Congrès Automnal de la Belgian Society for Cell and Developmental Biology (BSCDB).

JAMAR, M., HERENS, C., MENTEN, C., Sticca, T., & CABERG, J.-H. (20 September 2016). Corrélation entre les caryotypes standard et moléculaire dans une série de 7 cas de LAL pédiatriques hyperdiploïdes [Poster presentation]. XXIIIème Colloque Association des Cytogénéticiens de Langue Française, Montpellier, France.

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (09 March 2016). EVALUATION OF SV2Alox/Cre TRANSGENIC MICE USING [18F]UCB-H IN VITRO AUTORADIOGRAPHY [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

MENTEN, C.* , Serrano Navacerrada, M. E.* , Bartholomé, O., Gil, J. S., Neirinckx, V., Wislet, S., Becker, G., Plenevaux, A., Van Den Ackerveken, P.* , & Rogister, B.*. (2016). Development and validation of a new mouse model to investigate the role of sv2a in epilepsy. PLoS ONE. doi:10.1371/journal.pone.0166525
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (04 September 2015). EVALUATION OF SV2Alox/Cre TRANSGENIC MOUSE USING [18F]UCB-H IN IN VITRO AUTORADIOGRAPHY [Poster presentation]. International Symposium "Aging and sleep: Perks for longevity?, Liège, Belgium.

Belle, L., BINSFELD, M., DUBOIS, S., Hannon, M., Caers, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (February 2013). Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin. Biology of Blood and Marrow Transplantation, 19, 317.
Peer Reviewed verified by ORBi

Bonnet, C., MENTEN, C., LAMBERT, F., Gothot, A., Baron, F., CAERS, J., HERENS, C., & Beguin, Y. (25 January 2013). Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones [Poster presentation]. BHS, General Annual Meeting.

Belle, L., Binsfeld, M., HANNON, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (2013). Combination of Regulatory T Cells Injection with Rapamycin for Treatment of Chronic Graft-versus-Host Disease. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

Belle, L., Binsfeld, M., Dubois, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & BARON, F. (2013). Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin [Poster presentation]. BMT Tandem Meetings (ASBMT), Salt Lake City, United States.

Belle, L., Binsfeld, M., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., Beguin, Y., Humblet-Baron, S., & BARON, F. (2013). Combination of Regulatory T Cells Injection with Rapamycin for Treatment of Chronic Graft-versus-Host Disease [Paper presentation]. 28th General Meeting of the Belgian Hematological Society.

Menten, C., Faccinetto, C., Golovchenko, M., Dupiereux-Fettweis, I., Van Lerberghe, P.-B., DUBOIS, S., Desmet, C., Elmoualij, B., Baron, F., Rudenko, N., Oury, C., Heinen, E., & Couvreur, B. (December 2012). Neutrophil Extracellular Traps (NET) Entrap and Kill Borrelia burgdorferi sensu stricto Spirochetes and Are not Affected by Ixodes ricinus Tick Saliva. Journal of Immunology, 189 (11), 5393-5401. doi:10.4049/jimmunol.1103771
Peer Reviewed verified by ORBi

Belle, L., BINSFELD, M., Dubois, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., Beguin, Y., Humbelt-Baron, S., & BARON, F. (April 2012). Rapamycin prevents experimental sclerodermatous chronic graft-versus-host disease in mice. Bone Marrow Transplantation, 47 Suppl 1.
Peer Reviewed verified by ORBi

MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). Evidence for Expansion of Host-derived CMV-specific CD8+ T cells after Allogeneic Transplantation with Non-Myeloablative Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16.

Belle, L., Binsfeld, M., DUBOIS, S., Hannon, M., CAERS, J., Briquet, A., MENTEN, C., Beguin, Y., Humblet-Baron, S., & Baron, F. (2012). Rapamycin prevents experimental sclerodermatous chronic graft-versus-host disease in mice [Paper presentation]. 38th EBMT Annual Meeting.

MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning? Haematologica, 97 (Supplement 1), 720.
Peer Reviewed verified by ORBi

Belle, L., Binsfeld, M., DUBOIS, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., Beguin, Y., Humblet-Baron, S., & Baron, F. (2012). Rapamycin Prevents Experimental Sclerodermatous Chronic Graft-versus-Host Disease in mice [Paper presentation]. 27th General Meeting of the Belgian Hematological Society.

Bruck, F., Baron, F., DUBOIS, S., BRIQUET, A., Hannon, M., Belle, L., MENTEN, C., Beguin, Y., & Humblet-Baron, S. (February 2011). Rapamycin Delays Xenogeneic Acute Graft Versus Host Disease (aGVHD) in Nod/Scid/Il2RγNull (NSG) Mice: Impact of Regulatory T Cells [Poster presentation]. ASBMT meeting 2011. doi:10.1016/j.bbmt.2010.12.535

MENTEN, C., couvreur, B., Jolois, O., Van Lerberghe, P.-B., Duwez, L., Drion, P., & Heinen, E. (2011). Kinetic study of the antibody response during the blood meal of Ixodes ricinus: Implication on plasma cell maturation in vivo and for anti-Ixodes vaccination. Vaccine. doi:10.1016/j.vaccine.2011.01.010
Peer Reviewed verified by ORBi

Bruck, F., BARON, F., Dubois, S., BRIQUET, A., Hannon, M., Belle, L., MENTEN, C., BEGUIN, Y., & Humblet-Baron, S. (2011). The mTor inhibitor rapamycin delays xenogeneic acute graft versus host disease (aGVHD) in NOD/SCID/IL2rgnull mice (NSG): impact of regulatory T cells [Poster presentation]. Belgian Hematological Society Annual General Meeting.

Bruck, F., BARON, F., Dubois, S., BRIQUET, A., Hannon, M., Belle, L., MENTEN, C., BEGUIN, Y., & Humblet-Baron, S. (2011). Rapamycin delays xenogeneic acute graft-versus-host disease (aGvHD) in NOD/SCID/IL2Rg NULL (NSG) mice: impact of regulatory T cells [Poster presentation]. ASBMT 2011.

Menten, C., Couvreur, B., Thellin, O., Drion, P., Herry, M., Jolois, O., & Heinen, E. (2008). Influence of the Ixodes ricinus tick blood-feeding on the antigen-specific antibody response in vivo. Vaccine, 26 (52), 6956-64. doi:10.1016/j.vaccine.2008.09.072
Peer Reviewed verified by ORBi

Beaufays, J., Adam, B., Menten, C., Fievez, L., Grosjean, A., Decrem, Y., Prevot, P.-P., Santini, S., Brasseur, R., Brossard, M., Vanhaeverbeek, M., Bureau, F., Heinen, E., Lins, L., Vanhamme, L., & Godfroid, E. (2008). Ir-LBP, an ixodes ricinus tick salivary LTB4-binding lipocalin, interferes with host neutrophil function. PLoS ONE, 3 (12), 3987. doi:10.1371/journal.pone.0003987
Peer Reviewed verified by ORBi

Contact ORBi